Walter Dain: Long-term bullish on the marketing capabilities of China Resources Sanjiu and the market potential of its vitamin D products.

Huatai Dai said in the performance briefing on May 15th that the cooperation between VitaD and CR Sanjiu in 2025 did not meet expectations, but the company remains optimistic about CR Sanjiu's marketing capabilities and the market potential of VitaD products. Both companies will continue to promote the improvement of VitaD products through cooperation, work hand in hand, achieve complementary advantages, and promote the development of performance and the realization of sales goals. Currently, there are no other drug cooperation agency plans between the two parties.